Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.2600
+0.0100 (4.00%)
Jul 20, 2026, 11:38 AM EST
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $823.74 thousand as of July 20, 2026. Its market cap has decreased by -26.16% in one year.
Market Cap
823.74K
Enterprise Value
-1.59M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
ChartMarket Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 823.74K, a decrease of -97.01%. That is a compound annual growth rate of -32.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 823.74K | -61.96% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abpro Holdings | 1.29M |
| Regenerative Medical Technology Group | 1.17M |
| Evofem Biosciences | 1.02M |
| ZyVersa Therapeutics | 931.03K |
| Lyra Therapeutics | 922.94K |
| Agentix | 801.34K |
| Emmaus Life Sciences | 800.15K |
| Burzynski Research Institute | 761.09K |